Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Selera Murni Tbk. (CSMI) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Cipta Selera Murni Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Selera Murni Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Cipta Selera Murni Tbk. trades at Rp129 (market cap 97.11B, 90.7M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 3.3× Cipta Selera Murni Tbk.'s market cap, and Cipta Selera Murni Tbk. is more actively traded (90.7M versus 7.6K). Which is the better fit depends on your goals.

CSMIDGNS
Market Cap
97.11B319B
Volume
90.7M7.6K
Lot
906.99K76
Turnover
11.99B1.74M
Average Price
132.21229.21
Value
11.99B1.74M
Indicative Equilibrium Price
122232
Indicative Equilibrium Volume
2.22K200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CSMI
View details
DGNS
View details

About Cipta Selera Murni Tbk.

PT Cipta Selera Murni Tbk (Company) was established based on Notarial Deed No. 167 dated July 25,1983 of Winanto Wiryomartani, S.H., in Jakarta.

Read more on CSMI

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS